MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Familial SCA2-parkinsonism presented as intractable oromandibular dystonia

K. Woo, B. Jeon, J. Lee (Seoul, Republic of Korea)

Meeting: 2018 International Congress

Abstract Number: 130

Keywords: Dystonia: Genetics, Parkinsonism, Spinocerebellar ataxias(SCA)

Session Information

Date: Saturday, October 6, 2018

Session Title: Genetics (Non-PD)

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: We report a patient of spinocerebellar ataxia type 2(SCA2)-parkinsonism family who developed oromandibular dystonia as the chief presentation.

Background: We previously described a Korean family of SCA2-parkinsonism, where genetic analysis revealed 40 CAG repeats in the ATXN2 gene. The affected members presented with typical parkinsonism without ataxia, resembling Parkinson disease (PD).

Methods: Clinical examination, imaging studies and familial genetic analysis were done.

Results: The patient presented to the clinic at age 58. He reported involuntary jaw opening that had persisted for 2 months. Sense of leg dragging and gait disturbance accompanied. There was no history of exposure to antipsychotics or other medications. On examination, oromandibular dystonia was prominent. Involuntary jaw opening, clenching and tongue protrusion continued. Systemic evaluation revealed mild degree of stooped posture and parkinsonian gait. Ataxia and EOM abnormality were absent. Genetic analysis for SCA2 showed ATXN2 expansion of 40 CAG repeats. Levodopa, anticholinergics, baclofen and clonazepam were not consistently effective for dystonia. He committed suicide at age 62. The other affected members showed typical PD without ataxia. Asymmetric resting tremor and bradykinesia developed over a slow course with good response to levodopa. Brain imaging showed no cerebellar atrophy. Fallypride PET showed relatively preserved striatal dopamine receptor densities while DAT imaging showed globally decreased dopamine transporter density in striatum, suggesting purely presynaptic parkinsonism like PD. None of the other affected members had oromandibular dystonia as in our patient of concern. The differential diagnosis would include Wilson’s disease, Lubag, Fahr disease and NBIA syndromes. Magnetic resonance imaging was unremarkable. CIT-PET showed globally decreased uptake in both putamina. However, his family history pointed toward SCA2, which was positive.

Conclusions: This is the first case of SCA2-parkinsonism that presented chiefly with oromandibular dystonia. This demonstrates that intrafamilial heterogeneity exists within the single SCA2-parkinsonism kindred. In the previous report of this family, we suggested SCA2-parkinsonism be considered in the workup of familial PD even without ataxia. This case contributes to broadening the indication of the workup. SCA2 may need to be studied in patients with oromandibular dystonia who have family history.

To cite this abstract in AMA style:

K. Woo, B. Jeon, J. Lee. Familial SCA2-parkinsonism presented as intractable oromandibular dystonia [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/familial-sca2-parkinsonism-presented-as-intractable-oromandibular-dystonia/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/familial-sca2-parkinsonism-presented-as-intractable-oromandibular-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley